CAPTRUST Financial Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $139M | Sell |
293,489
-2,305
| -0.8% | -$1.16M | 0.24% | 78 |
|
|
2025
Q4 | $138M | Sell |
295,794
-9,911
| -3% | -$4.6M | 0.26% | 72 |
|
|
2025
Q3 | $130M | Buy |
305,705
+2,570
| +0.8% | +$996K | 0.27% | 74 |
|
|
2025
Q2 | $116M | Sell |
303,135
-252
| -0.1% | -$90.8K | 0.26% | 76 |
|
|
2025
Q1 | $105M | Sell |
303,387
-2,570
| -0.8% | -$827K | 0.26% | 76 |
|
|
2024
Q4 | $91.8M | Buy |
305,957
+2,929
| +1% | +$1.02M | 0.26% | 80 |
|
|
2024
Q3 | $123M | Sell |
303,028
-2,592
| -0.8% | -$949K | 0.37% | 56 |
|
|
2024
Q2 | $98.2M | Buy |
305,620
+544
| +0.2% | +$177K | 0.32% | 66 |
|
|
2024
Q1 | $102M | Sell |
305,076
-4,703
| -2% | -$1.44M | 0.37% | 60 |
|
|
2023
Q4 | $83.9M | Sell |
309,779
-13,951
| -4% | -$3.45M | 0.29% | 80 |
|
|
2023
Q3 | $79.6M | Sell |
323,730
-1,744
| -0.5% | -$477K | 0.3% | 73 |
|
|
2023
Q2 | $98.8M | Sell |
325,474
-5,193
| -2% | -$1.44M | 0.39% | 55 |
|
|
2023
Q1 | $87.2M | Buy |
330,667
+319,947
| +2,985% | +$81.3M | 0.38% | 56 |
|
|
2022
Q4 | $2.57M | Buy |
10,720
+492
| +5% | +$110K | 0.01% | 635 |
|
|
2022
Q3 | $1.88M | Buy |
10,228
+4,175
| +69% | +$832K | 0.01% | 694 |
|
|
2022
Q2 | $1.02M | Buy |
6,053
+1,481
| +32% | +$318K | 0.01% | 827 |
|
|
2022
Q1 | $1.15M | Buy |
4,572
+850
| +23% | +$213K | 0.01% | 789 |
|
|
2021
Q4 | $956K | Sell |
3,722
-766
| -17% | -$187K | 0.01% | 834 |
|
|
2021
Q3 | $1.09M | Buy |
4,488
+663
| +17% | +$162K | 0.01% | 719 |
|
|
2021
Q2 | $791K | Buy |
3,825
+15
| +0.4% | +$3.06K | 0.01% | 812 |
|
|
2021
Q1 | $718K | Buy |
3,810
+2,463
| +183% | +$434K | 0.01% | 812 |
|
|
2020
Q4 | $222K | Hold |
1,347
| – | – | ﹤0.01% | 1147 |
|
|
2020
Q3 | $168K | Buy |
1,347
+530
| +65% | +$65.6K | ﹤0.01% | 1113 |
|
|
2020
Q2 | $80K | Buy |
+817
| New | +$84.9K | ﹤0.01% | 1426 |
|
|
2019
Q4 | – | Sell |
-169
| Closed | -$20K | – | 1343 |
|
|
2019
Q3 | $20K | Buy |
169
+6
| +4% | +$775 | ﹤0.01% | 1297 |
|
|
2019
Q2 | $22K | Sell |
163
-75
| -32% | -$9.48K | ﹤0.01% | 1249 |
|
|
2019
Q1 | $31K | Buy |
238
+88
| +59% | +$11.8K | ﹤0.01% | 1031 |
|
|
2018
Q4 | $19K | Hold |
150
| – | – | ﹤0.01% | 1034 |
|
|
2018
Q3 | $21K | Hold |
150
| – | – | ﹤0.01% | 984 |
|
|
2018
Q2 | $15K | Hold |
150
| – | – | ﹤0.01% | 1047 |
|
|
2018
Q1 | $14K | Hold |
150
| – | – | ﹤0.01% | 939 |
|
|
2017
Q4 | $13K | Buy |
+150
| New | +$12.1K | ﹤0.01% | 931 |
|
Other funds holding HCA
VCM
VPM
CAPTRUST Financial Advisors's HCA Position: Q1 2026 in Review
CAPTRUST Financial Advisors reduced its HCA Healthcare (HCA) stake by 0.78% in Q1 2026, selling an estimated $1.16M and leaving 293,489 shares worth $139M. The position accounts for 0.24% of the portfolio, ranked #78.
CAPTRUST Financial Advisors first reported a position in HCA in Q4 2017 and has held it in 32 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- CAPTRUST Financial Advisors held 293,489 shares of HCA Healthcare worth $139M as of Q1 2026.
- CAPTRUST Financial Advisors sold 2,305 HCA Healthcare shares in Q1 2026, an estimated $1.16M.
- HCA Healthcare made up 0.24% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #78 holding.
- CAPTRUST Financial Advisors first reported a position in HCA Healthcare in Q4 2017 and has held it in 32 quarters since.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.